Back to Journals » Vascular Health and Risk Management » Volume 6

Vascular Health and Risk Management


Archive: Volume 6, 2010

COSEHC global vascular risk management quality improvement program: rationale and design

Carlos M Ferrario, Michael A Moore, William Bestermann Jr, et al

Vascular Health and Risk Management 2010, 6:1135-1145

Published Date: 13 December 2010

Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing

Emily Dey-Hazra, Barbara Hertel, Torsten Kirsch, et al

Vascular Health and Risk Management 2010, 6:1125-1133

Published Date: 6 December 2010

Inhaled treprostinil and pulmonary arterial hypertension

Samuel T Nadler, Jeffrey D Edelman

Vascular Health and Risk Management 2010, 6:1115-1124

Published Date: 3 December 2010

Lower extremity arterial injuries over a six-year period: outcomes, risk factors, and management

Aşkin Ender Topal, Mehmet Nesimi Eren, Yusuf Celik

Vascular Health and Risk Management 2010, 6:1103-1110

Published Date: 3 December 2010

Insulin therapy in critically ill patients

Samer Ellahham

Vascular Health and Risk Management 2010, 6:1089-1101

Published Date: 1 December 2010

Optimal management of familial hypercholesterolemia: treatment and management strategies

Mohammad Hassan Nemati, Behrooz Astaneh

Vascular Health and Risk Management 2010, 6:1079-1088

Published Date: 3 December 2010

Percutaneous coronary intervention of a single coronary artery arising from the right sinus of Valsalva

Mehmet Akif Cakar, Ersan Tatli, Bilhan Ozalp, et al

Vascular Health and Risk Management 2010, 6:1077-1078

Published Date: 25 November 2010

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy

William Insull Jr, Peter P Toth, H Robert Superko, et al

Vascular Health and Risk Management 2010, 6:1065-1075

Published Date: 24 November 2010

Cardio classics revisited – focus on the role of candesartan

Maria Leonarda De Rosa

Vascular Health and Risk Management 2010, 6:1047-1063

Published Date: 23 November 2010

Computerized history-taking as a tool to manage dyslipidemia

David Zakim, Christine Fritz, Niko Braun, et al

Vascular Health and Risk Management 2010, 6:1039-1046

Published Date: 12 November 2010

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia

Ian Hamilton-Craig, Karam Kostner, David Colquhoun, et al

Vascular Health and Risk Management 2010, 6:1023-1037

Published Date: 10 November 2010

Prognostic value of changes in arterial stiffness in men with coronary artery disease

Iana A Orlova, Eradzh Yu Nuraliev, Elena B Yarovaya, et al

Vascular Health and Risk Management 2010, 6:1015-1021

Published Date: 4 November 2010

Effects of safflower seed extract on arterial stiffness

Katsuya Suzuki, Shigekazu Tsubaki, Masami Fujita, et al

Vascular Health and Risk Management 2010, 6:1007-1014

Published Date: 3 November 2010

Low high-density lipoprotein cholesterol: current status and future strategies for management

Vibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al

Vascular Health and Risk Management 2010, 6:979-996

Published Date: 29 October 2010

Hypothyroidism and the risk of lower extremity arterial disease

Michael A Mazzeffi, Hung-Mo Lin, Brigid C Flynn, et al

Vascular Health and Risk Management 2010, 6:957-962

Published Date: 20 October 2010

Risk assessment and aspirin use in Asian and Western populations

Runlin Gao, Xiaoying Li

Vascular Health and Risk Management 2010, 6:943-956

Published Date: 14 October 2010

Diagnostic accuracy of dual-source CT angiography and coronary risk stratification

Xia Yang, Lu-yue Gai, Ping Li, et al

Vascular Health and Risk Management 2010, 6:935-941

Published Date: 14 October 2010

Impact of a diabetic foot care education program on lower limb amputation rate

Abdullah M Al-Wahbi

Vascular Health and Risk Management 2010, 6:923-934

Published Date: 11 October 2010

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population

Nicole M Engel-Nitz, Stephen D Sander, Carolyn Harley, et al

Vascular Health and Risk Management 2010, 6:905-913

Published Date: 5 October 2010

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies

Christina Voulgari, Dimitrios Papadogiannis, Nicholas Tentolouris

Vascular Health and Risk Management 2010, 6:883-903

Published Date: 11 October 2010

New class of agents for treatment of hypertension: Focus on direct renin inhibition

Roberto Fogari, Annalisa Zoppi

Vascular Health and Risk Management 2010, 6:869-882

Published Date: 1 October 2010

Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update

Juan V Llau, Raquel Ferrandis, Pilar Sierra, et al

Vascular Health and Risk Management 2010, 6:855-867

Published Date: 29 September 2010

Benefits of statin therapy and compliance in high risk cardiovascular patients

Joel A Lardizabal, Prakash C Deedwania

Vascular Health and Risk Management 2010, 6:843-853

Published Date: 23 September 2010

Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study

Laura J Gray, Jennifer R Tringham, Melanie J Davies, et al

Vascular Health and Risk Management 2010, 6:837-842

Published Date: 20 September 2010

Argatroban in the management of heparin-induced thrombocytopenia

Luciano Babuin, Vittorio Pengo

Vascular Health and Risk Management 2010, 6:813-819

Published Date: 1 September 2010

Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice

Peter Bramlage, Wolf-Peter Wolf, Thomas Stuhr, et al

Vascular Health and Risk Management 2010, 6:803-811

Published Date: 27 August 2010

Role of endothelin receptor A and NADPH oxidase in vascular abnormalities

De-Zai Dai, Yin Dai

Vascular Health and Risk Management 2010, 6:787-794

Published Date: 3 September 2010

Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review

Suzanne A Ligthart, Eric P Moll van Charante, Willem A Van Gool, et al

Vascular Health and Risk Management 2010, 6:775-785

Published Date: 17 August 2010

Effectiveness of percutaneous laser revascularization therapy for refractory angina

Michael McGillion, Allison Cook, J Charles Victor, et al

Vascular Health and Risk Management 2010, 6:735-747

Published Date: 26 August 2010

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells

Myriam Iglewski, Stephen R Grant

Vascular Health and Risk Management 2010, 6:723-734

Published Date: 11 August 2010

Role of olmesartan in combination therapy in blood pressure control and vascular function

Carlos M Ferrario, Ronald D Smith

Vascular Health and Risk Management 2010, 6:701-709

Published Date: 9 August 2010

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment

Curtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo

Vascular Health and Risk Management 2010, 6:671-690

Published Date: 5 August 2010

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction

Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al

Vascular Health and Risk Management 2010, 6:657-663

Published Date: 26 August 2010

Estimating glomerular filtration rate in a population-based study

Anoop Shankar, Kristine E Lee, Barbara EK Klein, et al

Vascular Health and Risk Management 2010, 6:619-627

Published Date: 16 July 2010

Management of high-risk popliteal vascular blunt trauma: clinical experience with 62 cases

Ali Pourzand, Bassir A Fakhri, Ramin Azhough, et al

Vascular Health and Risk Management 2010, 6:613-618

Published Date: 14 July 2010

Cardiac risk stratification: Role of the coronary calcium score

Rakesh K Sharma, Rajiv K Sharma, Donald J Voelker, et al

Vascular Health and Risk Management 2010, 6:603-611

Published Date: 14 July 2010

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

Claudio A Muratore, Adrian Baranchuk

Vascular Health and Risk Management 2010, 6:593-601

Published Date: 14 July 2010

Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome

Kanako Bokuda, Atsuhiro Ichihara, Mariyo Sakoda, et al

Vascular Health and Risk Management 2010, 6:571-578

Published Date: 5 July 2010

Practical recommendations for treatment of hypertension in older patients

Philip A Kithas, Mark A Supiano

Vascular Health and Risk Management 2010, 6:561-569

Published Date: 29 June 2010

Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination

Francesca Cagnoni, Christian Achiri Ngu Njwe, Augusto Zaninelli, et al

Vascular Health and Risk Management 2010, 6:549-559

Published Date: 28 June 2010

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid

Elisavet Moutzouri, Anastazia Kei, Moses S Elisaf, et al

Vascular Health and Risk Management 2010, 6:525-539

Published Date: 29 June 2010

Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy

Deborah Wolbrette, Mario Gonzalez, Soraya Samii, et al

Vascular Health and Risk Management 2010, 6:517-523

Published Date: 28 June 2010

Clinical profile of hypertension at a University Teaching Hospital in Nigeria

Arthur C Onwuchekwa, Sunday Chinenye

Vascular Health and Risk Management 2010, 6:511-516

Published Date: 1 July 2010

Transradial approach to lower extremity interventions

Ravikiran Korabathina, Sidharth S Yadav, John T Coppola, et al

Vascular Health and Risk Management 2010, 6:503-509

Published Date: 1 July 2010

Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG

Sandra Eifert, Helmut Mair, Anne-Laure Boulesteix, et al

Vascular Health and Risk Management 2010, 6:495-501

Published Date: 29 June 2010

Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection

Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al

Vascular Health and Risk Management 2010, 6:479-494

Published Date: 22 June 2010

Congestive heart failure in subjects with thyrotoxicosis in a black community

R C Anakwue, B J C Onwubere, B C Anisiuba, et al

Vascular Health and Risk Management 2010, 6:473-477

Published Date: 5 July 2010

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

Inder S Anand, Anita Deswal, Dean J Kereiakes, et al

Vascular Health and Risk Management 2010, 6:449-455

Published Date: 1 June 2010

Novel approaches for the surgical treatment of atrial fibrillation: Time for a guideline revision?

Carlo Nicola De Cecco, Vitaliano Buffa, Vincenzo David, et al

Vascular Health and Risk Management 2010, 6:439-447

Published Date: 9 June 2010

Influence of demographic and metabolic variables on forearm blood flow and vascular conductance in individuals without overt heart disease

Thiago E Sartori, Rafael AB Nunes, Gisela T da Silva, et al

Vascular Health and Risk Management 2010, 6:431-437

Published Date: 31 May 2010

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor

Margaret M Marczewski, Marek Postula, Dariusz Kosior

Vascular Health and Risk Management 2010, 6:419-429

Published Date: 24 May 2010

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure

A Palazzuoli, M Gallotta, I Quatrini, et al

Vascular Health and Risk Management 2010, 6:411-418

Published Date: 26 May 2010

Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine

David Feldman, Terry S Elton, Doron M Menachemi, et al

Vascular Health and Risk Management 2010, 6:387-397

Published Date: 24 May 2010

Isolated spontaneous dissection of the celiac trunk in a patient with bicuspid aortic valve

Abdel-Rauf Zeina, Alicia Nachtigal, Anton Troitsa, et al

Vascular Health and Risk Management 2010, 6:383-386

Published Date: 19 May 2010

Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes

Magnus Dencker, Martin Stagmo, Mozhgan Dorkhan

Vascular Health and Risk Management 2010, 6:373-382

Published Date: 18 May 2010

New options with dabigatran etexilate in anticoagulant therapy

Lars Maegdefessel, Joshua M Spin, Junya Azuma, et al

Vascular Health and Risk Management 2010, 6:339-349

Published Date: 10 May 2010

Should we screen for masked hypertension in patient with vascular disease?

Pascal Delsart, Philippe Marboeuf, Cedric Delhaye, et al

Vascular Health and Risk Management 2010, 6:333-338

Published Date: 10 May 2010

Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics

Mabrouka El Oudi, Zied Aouni, Haroun Ouertani, et al

Vascular Health and Risk Management 2010, 6:327-332

Published Date: 13 May 2010

Volumetric capnography: In the diagnostic work-up of chronic thromboembolic disease

Marcos Mello Moreira, Renato Giuseppe Giovanni Terzi, Laura Cortellazzi, et al

Vascular Health and Risk Management 2010, 6:317-319

Published Date: 17 May 2010

Coronary computed tomographic angiography (CCTA) in community hospitals: “current and emerging role”

Rakesh K Sharma, Donald J Voelker, Rajiv K Sharma, et al

Vascular Health and Risk Management 2010, 6:307-316

Published Date: 10 May 2010

Mortality following operations for lower extremity peripheral arterial disease

Tracie C Collins, David Nelson, Jasjit S Ahluwalia

Vascular Health and Risk Management 2010, 6:287-296

Published Date: 3 May 2010

Predictors of obstructive sleep apnea in males with metabolic syndrome

Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al

Vascular Health and Risk Management 2010, 6:281-286

Published Date: 20 April 2010

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension

Jeremy A Falk, Kiran J Philip, Ernst R Schwarz

Vascular Health and Risk Management 2010, 6:273-280

Published Date: 20 April 2010

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update

Maurizio Destro, Francesca Cagnoni, Antonio D’Ospina, et al

Vascular Health and Risk Management 2010, 6:253-260

Published Date: 14 April 2010

Managing anemia in patients with chronic heart failure: what do we know?

Ankur Sandhu, Sandeep Soman, Michael Hudson, et al

Vascular Health and Risk Management 2010, 6:237-252

Published Date: 7 April 2010

Atorvastatin in stroke: a review of SPARCL and subgroup analysis

Branko N Huisa, Andrew B Stemer, Justin A Zivin

Vascular Health and Risk Management 2010, 6:229-236

Published Date: 30 March 2010

Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function

Poulami Basu, Utpal Sen, Neetu Tyagi,  et al

Vascular Health and Risk Management 2010, 6:215-228

Published Date: 30 March 2010

Recent achievements in the management of Raynaud’s phenomenon

Magnus Baumhäkel, Michael Böhm

Vascular Health and Risk Management 2010, 6:207-214

Published Date: 30 March 2010

Does plasmin have anticoagulant activity?

Jane Hoover-Plow

Vascular Health and Risk Management 2010, 6:199-205

Published Date: 26 March 2010

Advances in the treatment of Raynaud’s phenomenon

Terri L Levien

Vascular Health and Risk Management 2010, 6:167-177

Published Date: 11 March 2010

Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients

Pongsathorn Gojaseni, Angkana Phaopha, Worawon Chailimpamontree, et al

Vascular Health and Risk Management 2010, 6:157-165

Published Date: 11 March 2010

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

Ajikumar V Aryangat, John E Gerich

Vascular Health and Risk Management 2010, 6:145-155

Published Date: 9 March 2010

The diagnostic value of endothelial function as a potential sensor of fatigue in health

Yoshiko Ohno, Teruto Hashiguchi, Ryuichi Maenosono, et al

Vascular Health and Risk Management 2010, 6:135-144

Published Date: 9 March 2010

New standards in hypertension and cardiovascular risk management: focus on telmisartan

Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al

Vascular Health and Risk Management 2010, 6:113-133

Published Date: 4 March 2010

A newly designed hydroxyapatite ceramic burr-hole button

Hiroshi Kashimura, Kuniaki Ogasawara, Yoshitaka Kubo, et al

Vascular Health and Risk Management 2010, 6:105-108

Published Date: 3 March 2010

Modern role for clopidogrel in management of atrial fibrillation and stroke reduction

Lars Maegdefessel, Junya Azuma, Philip S Tsao

Vascular Health and Risk Management 2010, 6:95-103

Published Date: 26 February 2010

On the antiatherogenic effects of vitamin E: the search for the Holy Grail

Francesco Galli, Dimitrios Kirmizis, Dimitrios Chatzidimitriou

Vascular Health and Risk Management 2010, 6:69-71

Published Date: 16 February 2010

Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention

Jennifer Vergara-Jimenez, Pierluigi Tricoci

Vascular Health and Risk Management 2010, 6:39-45

Published Date: 2 March 2010

Successful management of late right ventricular perforation after pacemaker implantation

Amir K Bigdeli, Andres Beiras-Fernandez, Ingo Kaczmarek, et al

Vascular Health and Risk Management 2010, 6:27-30

Published Date: 6 January 2010

Role of ICAM-1 and E-selectin gene polymorphisms in pathogenesis of PAOD in Egyptian patients

Olfat Shaker, Amr Zahra, Ahmed Sayed, et al

Vascular Health and Risk Management 2010, 6:9-15

Published Date: 24 December 2009

Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients

Jamison Wyatt, Shailesh Nandish, Rene Oliveros, et al

Vascular Health and Risk Management 2010, 6:1-8

Published Date: 23 December 2009